FDA and CDC are set to call for Johnson & Johnson COVID vaccine to be paused

The Food and Drug Administration and the Centers for Disease Control are set to call for Johnson & Johnson’s single-dose vaccine to be stopped in the U.S. after six women developed blood clots.   

The two federal authorities will stop using the vaccine at federal sites and will urge states to do so too, according to the New York Times. 

Seven million people in the U.S. have recieved the Johnson & Johnson vaccine and the six recipients who developed the clots were aged between 18 and 48. 

A medical professional from UofL Health administers a vaccine to a patient in their vehicle at University of Louisville Cardinal Stadium in Kentucky on Tuesday